Lars Haahr

Chief Executive Officer at House of Denmark A/S

Consumer Non-Durables

Network origin in Lars Haahr first degree

Entity	Entity type	Industry
House of Denmark A/S House of Denmark A/S Food: Specialty/CandyConsumer Non-Durables House of Denmark A/S offers product including dried fruit, biscuits, cakes, and fruit snacks. The firm provides products for children consist of fruit mix, raisins, and fruit bars in various practical packaging. The company was founded in 2002 and is headquartered in Vejle Ost, Denmark. 2	Private Company	Food: Specialty/Candy	2

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Lars Haahr via their personal network

Company	Sector	Related people	Main position
NOVO NORDISK A/S	Pharmaceuticals: Major	Peter Helt Jacobsen Haahr	Public Communications Contact
Novo Invest 2B AS Novo Invest 2B AS Financial ConglomeratesFinance Novo Invest 2B AS is an investment holding Danish company.	Financial Conglomerates	Peter Helt Jacobsen Haahr	Director/Board Member
LEO Pharma A/S LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.	Pharmaceuticals: Major	Peter Helt Jacobsen Haahr	Director/Board Member
LEO Holding A/S (Denmark) LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark.	Financial Conglomerates	Peter Helt Jacobsen Haahr	Chief Executive Officer
LEO Fondet LEO Fondet BiotechnologyHealth Technology LEO Fondet provides support for research in the fields of medicine, chemistry, and pharmacy. The company was founded on August 20, 1984 and is headquartered in Ballerup, Denmark.	Biotechnology	Peter Helt Jacobsen Haahr	Chief Executive Officer
Sonion Holdco A/S Sonion Holdco A/S Financial ConglomeratesFinance Part of Sonion A/S, Sonion Holdco A/S is an investment holding Danish company. The company is based in Hellerup, Denmark.	Financial Conglomerates	Peter Helt Jacobsen Haahr	Director/Board Member
Xellia Holdco A/S		Peter Helt Jacobsen Haahr	Director/Board Member
Env Holdcoco AS Env Holdcoco AS Financial ConglomeratesFinance Env Holdcoco AS is an investment holding Danish company.	Financial Conglomerates	Peter Helt Jacobsen Haahr	Director/Board Member
Novo Invest 2C AS Novo Invest 2C AS Financial ConglomeratesFinance Novo Invest 2C AS is an investment holding Danish company.	Financial Conglomerates	Peter Helt Jacobsen Haahr	Director/Board Member
Novo Invest 2A A/S		Peter Helt Jacobsen Haahr	Director/Board Member
NNIT A/S	Information Technology Services	Peter Helt Jacobsen Haahr	Director/Board Member
Novo Invest 2 AS Novo Invest 2 AS Financial ConglomeratesFinance Novo Invest 2 AS functions as an investment holding Danish company.	Financial Conglomerates	Peter Helt Jacobsen Haahr	Director/Board Member
Novo Invest 1 A/S Novo Invest 1 A/S Financial ConglomeratesFinance Novo Invest 1 A/S provides investment services. The private company is based in Hellerup, Denmark.	Financial Conglomerates	Peter Helt Jacobsen Haahr	Director/Board Member
Novo Capital Investors ApS		Peter Helt Jacobsen Haahr	Director/Board Member
Novo Capital Investors PS		Peter Helt Jacobsen Haahr	Director/Board Member
International Institute for Management Development	College/University	Peter Helt Jacobsen Haahr	Masters Business Admin
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	Pharmaceuticals: Major	Peter Helt Jacobsen Haahr	Director/Board Member
Novo Holdings A/S (Investment Company) Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets.	Financial Conglomerates	Peter Helt Jacobsen Haahr	Director of Finance/CFO
Aarhus Business College	College/University	Peter Helt Jacobsen Haahr	Graduate Degree
Leo Pharma, Inc. Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ.	Drugstore Chains	Peter Helt Jacobsen Haahr	Director/Board Member